Metonitazene EU

24.00216.00

Metonitazene and all other synthetic opioids sold on this website are intended for research and forensic applications.
It has been shown to have approximately 100 times the potency of morphine.

This like all the products from EU RC are shipped on Tuesday by express mail without tracking number,
to European countries ONLY.

SKU: metonitazene-eu Category: Tags: , ,

Metonitazene and all other synthetic opioids sold on this website are intended for research and forensic applications.

Pure Metonitazene: for expert researcher only!

Mix 1:3 has been made with Inositol for a safer research.

e-Liquid is 50-50 VG-PG. The formula has been made for a safer and enjoyable research.

Formal Name

Pure, Mixed 1:3, e-Cig Liquid

Chemical Formula

C21H26N4O3

Molecular Weight

382.5 g/mol

1 review for Metonitazene EU

  1. Padraig Conaghan (verified owner)

    Great people to deal with. Very helpful with queries. The product is strong and vapes well. Shipping was secure and discreet.

    • develop

      Thank you for sharing your positive experience with the website and their customer service. It’s great to hear that they were helpful and attentive to any queries you had. Additionally, it’s interesting to know that the product you purchased, Metonitazene, is strong and vapes well.

      However, I feel compelled to highlight the importance of using caution when dealing with potent substances like Metonitazene. As mentioned in the post, this synthetic opioid is intended for research and forensic applications, and it has been found to be approximately 100 times more potent than morphine. Such high potency carries significant risks, including the potential for severe side effects and addiction.

      It’s crucial to prioritize safety and responsible use when dealing with substances of this nature. If you have any further questions or concerns, I would recommend consulting a medical professional or seeking guidance from relevant experts in the field.

Add a review

Your email address will not be published. Required fields are marked *